BR0209282A - Antibacterial composition - Google Patents
Antibacterial compositionInfo
- Publication number
- BR0209282A BR0209282A BR0209282-4A BR0209282A BR0209282A BR 0209282 A BR0209282 A BR 0209282A BR 0209282 A BR0209282 A BR 0209282A BR 0209282 A BR0209282 A BR 0209282A
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial
- antibacterial composition
- amino acid
- relates
- cytoskeleton
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 4
- 102100030801 Elongation factor 1-alpha 1 Human genes 0.000 abstract 2
- 108010049977 Peptide Elongation Factor Tu Proteins 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004292 cytoskeleton Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"COMPOSIçãO ANTIBACTERIANA". A presente invenção refere-se à aplicação de substâncias, que ligam no fator de translação bacteriano EF-Tu, para a inibição da formação de um citoesqueleto em células bacterianas e para a preparação de composições antiacterianas. Além disso, a invenção refere-se a composições bacterianas, que contêm fragmentos das seq³ências de aminoácidos dos domínios 2 e/ou 3 de uma proteína EF-Tu bacteriana com um comprimento de preferentemente 4-20 aminoácidos."ANTIBACTERIAL COMPOSITION". The present invention relates to the application of substances which bind on the bacterial translational factor EF-Tu for inhibiting the formation of a cytoskeleton in bacterial cells and for the preparation of anti-bacterial compositions. Further, the invention relates to bacterial compositions containing fragments of the amino acid sequences of domains 2 and / or 3 of a bacterial EF-Tu protein of preferably 4-20 amino acid length.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10121145 | 2001-04-30 | ||
| DE10129870A DE10129870A1 (en) | 2001-04-30 | 2001-06-21 | Antibacterial |
| PCT/EP2002/004410 WO2002087554A2 (en) | 2001-04-30 | 2002-04-22 | Ef-tu binding agent as antibacterial agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0209282A true BR0209282A (en) | 2004-07-27 |
Family
ID=26009202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0209282-4A BR0209282A (en) | 2001-04-30 | 2002-04-22 | Antibacterial composition |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1397157A2 (en) |
| JP (1) | JP2004534016A (en) |
| CN (1) | CN1298739C (en) |
| AU (1) | AU2002302555B2 (en) |
| BG (1) | BG108399A (en) |
| BR (1) | BR0209282A (en) |
| CA (1) | CA2445995A1 (en) |
| CZ (1) | CZ20033271A3 (en) |
| EE (1) | EE200300530A (en) |
| HU (1) | HUP0401586A3 (en) |
| IL (1) | IL158627A0 (en) |
| MX (1) | MXPA03009954A (en) |
| NZ (1) | NZ529662A (en) |
| PL (1) | PL366836A1 (en) |
| RU (1) | RU2003134636A (en) |
| SK (1) | SK14792003A3 (en) |
| WO (1) | WO2002087554A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10229645A1 (en) * | 2002-07-02 | 2004-05-19 | Kuchenreuther, Ulrich, Dr. | Cell disruption of bacteria |
| AU2010278860B2 (en) | 2009-07-31 | 2016-05-26 | Thar Pharma, Llc | Crystallization method and bioavailability |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
| CN105218668B (en) * | 2015-10-30 | 2020-03-24 | 山东农业大学 | EF-Tu protein monoclonal antibody MAb of Brucella malta and its preparation method and application |
| US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0466251A1 (en) * | 1990-07-10 | 1992-01-15 | Gist-Brocades N.V. | Elfamycin-resistant mutants |
| ATE343642T1 (en) * | 1998-01-23 | 2006-11-15 | Biomerieux Bv | EF-TU MRNA AS A MARKER FOR VIABLE BACTERIA |
| US6451556B1 (en) * | 1998-12-21 | 2002-09-17 | Smithkline Beecham Corporation | EF-Tu |
-
2002
- 2002-04-22 CZ CZ20033271A patent/CZ20033271A3/en unknown
- 2002-04-22 WO PCT/EP2002/004410 patent/WO2002087554A2/en not_active Ceased
- 2002-04-22 EP EP02730187A patent/EP1397157A2/en not_active Withdrawn
- 2002-04-22 RU RU2003134636/13A patent/RU2003134636A/en unknown
- 2002-04-22 AU AU2002302555A patent/AU2002302555B2/en not_active Ceased
- 2002-04-22 SK SK1479-2003A patent/SK14792003A3/en unknown
- 2002-04-22 NZ NZ529662A patent/NZ529662A/en unknown
- 2002-04-22 JP JP2002584900A patent/JP2004534016A/en active Pending
- 2002-04-22 PL PL02366836A patent/PL366836A1/en unknown
- 2002-04-22 IL IL15862702A patent/IL158627A0/en unknown
- 2002-04-22 HU HU0401586A patent/HUP0401586A3/en unknown
- 2002-04-22 BR BR0209282-4A patent/BR0209282A/en not_active Application Discontinuation
- 2002-04-22 CA CA002445995A patent/CA2445995A1/en not_active Abandoned
- 2002-04-22 EE EEP200300530A patent/EE200300530A/en unknown
- 2002-04-22 CN CNB028102185A patent/CN1298739C/en not_active Expired - Fee Related
- 2002-04-22 MX MXPA03009954A patent/MXPA03009954A/en unknown
-
2003
- 2003-12-01 BG BG108399A patent/BG108399A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG108399A (en) | 2004-08-31 |
| WO2002087554A3 (en) | 2003-01-30 |
| WO2002087554A2 (en) | 2002-11-07 |
| HUP0401586A3 (en) | 2005-06-28 |
| WO2002087554B1 (en) | 2005-01-27 |
| PL366836A1 (en) | 2005-02-07 |
| EP1397157A2 (en) | 2004-03-17 |
| EE200300530A (en) | 2004-04-15 |
| SK14792003A3 (en) | 2004-07-07 |
| CN1298739C (en) | 2007-02-07 |
| MXPA03009954A (en) | 2005-07-25 |
| JP2004534016A (en) | 2004-11-11 |
| IL158627A0 (en) | 2004-05-12 |
| CN1518455A (en) | 2004-08-04 |
| CZ20033271A3 (en) | 2004-06-16 |
| HUP0401586A2 (en) | 2004-11-29 |
| CA2445995A1 (en) | 2002-11-07 |
| AU2002302555B2 (en) | 2007-08-23 |
| NZ529662A (en) | 2006-08-31 |
| RU2003134636A (en) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9910089A (en) | Compositions and antigens of neisseria meningitidis | |
| DE602004022056D1 (en) | ANTIBACTERIAL COMPOSITION, ESPECIALLY FOR COMBATING GRAMBEGATIVE BACTERIA, COMPREHENSIVELY A PEPTIDE AND A BENEFICIAL HYDROPHOBIC ANTIBACTERIAL AGENCY | |
| ATE188996T1 (en) | DNA SEQUENCES CODING FOR NOVEL GROWTH/DIFERENTATION FACTORS | |
| BR9713404A (en) | esters of n- (aryl / heteroarylacetyl) amino acids, pharmaceutical compositions comprising them, and methods for inhibiting the release of beta-amyloid peptide and / or its synthesis by using such compounds. | |
| BRPI0407058A (en) | Methods of prophylaxis and treatment of a disease, pharmaceutical composition, and use of a fragment | |
| BR0115427A (en) | Compound, pharmaceutical composition, methods for inhibiting the release of beta-amyloid peptide and / or its synthesis, for treating Alzheimer's disease, and for preventing the disease and the progress of Alzheimer's disease, and, use of a compound. | |
| HUP0002322A2 (en) | Multivalent vaccine composition with mixed carrier | |
| BRPI9915679B8 (en) | compositions and methods to increase bone mineralization | |
| BR0009564A (en) | Use of cyp2d6 inhibitors in combination therapies | |
| BRPI0511421A (en) | cosmetic and pharmaceutical compositions for treating keratin-containing materials, use of cosmetic compositions, keratin-binding effector molecule, use thereof, and process | |
| BR9914066A (en) | Human complement c3-degrading polypeptide from streptococcus pneumoniae | |
| UY24949A1 (en) | CALCILITE COMPOUNDS | |
| BR9406689A (en) | Defective recombinant adenovirus use of this adenovirus and pharmaceutical composition obtained | |
| DE60233532D1 (en) | SYNTHETIC ODE APPLICATIONS BINDING TO PROTEIN PHOSPHATASE 2A | |
| BR0316923A (en) | Mitoneet polypeptide of mitochondrial membranes, their modulators and methods for their use | |
| BR0014860A (en) | Methods for producing a target molecule in a transgenic animal and purifying the target molecule | |
| BR0209282A (en) | Antibacterial composition | |
| DE602004025265D1 (en) | NEW PHOSPHAT BINDING PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF | |
| BRPI0415781A (en) | Method for treating diabetes in a patient and pharmaceutical kit | |
| BR9510067A (en) | Peptide capable of interacting with the sh3 domain of the antibody gap protein or antibody fragment directed against a polypeptide nucleotide sequence encoding an antisense nucleic acid polypeptide capable of at least partially inhibiting the production of polypeptides its use pharmaceutical composition and use of an antibody or antibody fragment | |
| BR0208786A (en) | Method for identification of intracellular bacterial proteins | |
| BR9714049A (en) | Imidazopyridazines | |
| BR0212219A (en) | Peptide compounds that selectively bind to p-selectin | |
| BRPI9916549B8 (en) | PHARMACEUTICAL COMPOSITION, PROTEIN, POLYNUCLEOTIDE | |
| EP1073623A4 (en) | Substituted amino acids as erythropoietin mimetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |